247 related articles for article (PubMed ID: 33802349)
1. Inflammasome in ALS Skeletal Muscle:
Moreno-García L; Miana-Mena FJ; Moreno-Martínez L; de la Torre M; Lunetta C; Tarlarini C; Zaragoza P; Calvo AC; Osta R
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802349
[TBL] [Abstract][Full Text] [Related]
2. Targeting the NLRP3 Inflammasome With Inhibitor MCC950 Prevents Aortic Aneurysms and Dissections in Mice.
Ren P; Wu D; Appel R; Zhang L; Zhang C; Luo W; Robertson AAB; Cooper MA; Coselli JS; Milewicz DM; Shen YH; LeMaire SA
J Am Heart Assoc; 2020 Apr; 9(7):e014044. PubMed ID: 32223388
[TBL] [Abstract][Full Text] [Related]
3. Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury.
Xu X; Yin D; Ren H; Gao W; Li F; Sun D; Wu Y; Zhou S; Lyu L; Yang M; Xiong J; Han L; Jiang R; Zhang J
Neurobiol Dis; 2018 Sep; 117():15-27. PubMed ID: 29859317
[TBL] [Abstract][Full Text] [Related]
4. Activation of the NLRP3 Inflammasome Is Associated with Valosin-Containing Protein Myopathy.
Nalbandian A; Khan AA; Srivastava R; Llewellyn KJ; Tan B; Shukr N; Fazli Y; Kimonis VE; BenMohamed L
Inflammation; 2017 Feb; 40(1):21-41. PubMed ID: 27730320
[TBL] [Abstract][Full Text] [Related]
5. NLRP3 Inflammasome Activation in a Transgenic Amyotrophic Lateral Sclerosis Model.
Gugliandolo A; Giacoppo S; Bramanti P; Mazzon E
Inflammation; 2018 Feb; 41(1):93-103. PubMed ID: 28936769
[TBL] [Abstract][Full Text] [Related]
6. MCC950 Inhibits NLRP3 Inflammasome and Alleviates Axonal Injures in Early Stages of Diffuse Axonal Injury in Rats.
Zhao J; Guo X; Wang B; Yang Z; Huang T; Guo D; Zhang M; Song J
Neurochem Res; 2020 Sep; 45(9):2020-2031. PubMed ID: 32474832
[TBL] [Abstract][Full Text] [Related]
7. The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins.
Deora V; Lee JD; Albornoz EA; McAlary L; Jagaraj CJ; Robertson AAB; Atkin JD; Cooper MA; Schroder K; Yerbury JJ; Gordon R; Woodruff TM
Glia; 2020 Feb; 68(2):407-421. PubMed ID: 31596526
[TBL] [Abstract][Full Text] [Related]
8. Activation of the NLRP3 Inflammasome Increases the IL-1β Level and Decreases GLUT4 Translocation in Skeletal Muscle during Insulin Resistance.
Américo-Da-Silva L; Aguilera J; Quinteros-Waltemath O; Sánchez-Aguilera P; Russell J; Cadagan C; Meneses-Valdés R; Sánchez G; Estrada M; Jorquera G; Barrientos G; Llanos P
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638553
[TBL] [Abstract][Full Text] [Related]
9. NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report.
van der Heijden T; Kritikou E; Venema W; van Duijn J; van Santbrink PJ; Slütter B; Foks AC; Bot I; Kuiper J
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1457-1461. PubMed ID: 28596375
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the NLRP3 inflammasome reduces brain edema and regulates the distribution of aquaporin-4 after cerebral ischaemia-reperfusion.
Wang H; Chen H; Jin J; Liu Q; Zhong D; Li G
Life Sci; 2020 Jun; 251():117638. PubMed ID: 32251636
[TBL] [Abstract][Full Text] [Related]
11. Expression profile of pattern recognition receptors in skeletal muscle of SOD1
Lehmann S; Esch E; Hartmann P; Goswami A; Nikolin S; Weis J; Beyer C; Johann S
Neuropathol Appl Neurobiol; 2018 Oct; 44(6):606-627. PubMed ID: 29575052
[TBL] [Abstract][Full Text] [Related]
12. The effects of NLRP3 inflammasome inhibition by MCC950 on LPS-induced pancreatic adenocarcinoma inflammation.
Yaw ACK; Chan EWL; Yap JKY; Mai CW
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2219-2229. PubMed ID: 32507974
[TBL] [Abstract][Full Text] [Related]
13. α1-antitrypsin mitigates NLRP3-inflammasome activation in amyloid β
Ebrahimi T; Rust M; Kaiser SN; Slowik A; Beyer C; Koczulla AR; Schulz JB; Habib P; Bach JP
J Neuroinflammation; 2018 Sep; 15(1):282. PubMed ID: 30261895
[TBL] [Abstract][Full Text] [Related]
14. Ameliorative effect of selective NLRP3 inflammasome inhibitor MCC950 in an ovalbumin-induced allergic rhinitis murine model.
Zhang W; Ba G; Tang R; Li M; Lin H
Int Immunopharmacol; 2020 Jun; 83():106394. PubMed ID: 32193102
[TBL] [Abstract][Full Text] [Related]
15. Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice.
Dempsey C; Rubio Araiz A; Bryson KJ; Finucane O; Larkin C; Mills EL; Robertson AAB; Cooper MA; O'Neill LAJ; Lynch MA
Brain Behav Immun; 2017 Mar; 61():306-316. PubMed ID: 28003153
[TBL] [Abstract][Full Text] [Related]
16. The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction.
Gao R; Shi H; Chang S; Gao Y; Li X; Lv C; Yang H; Xiang H; Yang J; Xu L; Tang Y
Int Immunopharmacol; 2019 Sep; 74():105575. PubMed ID: 31299609
[TBL] [Abstract][Full Text] [Related]
17. NLRP3 inflammasome activates interleukin-23/interleukin-17 axis during ischaemia-reperfusion injury in cerebral ischaemia in mice.
Wang H; Zhong D; Chen H; Jin J; Liu Q; Li G
Life Sci; 2019 Jun; 227():101-113. PubMed ID: 31002919
[TBL] [Abstract][Full Text] [Related]
18. NLRP3 inflammasome inhibition attenuates cisplatin-induced renal fibrosis by decreasing oxidative stress and inflammation.
Li S; Lin Q; Shao X; Mou S; Gu L; Wang L; Zhang Z; Shen J; Zhou Y; Qi C; Jin H; Pang H; Ni Z
Exp Cell Res; 2019 Oct; 383(1):111488. PubMed ID: 31276670
[TBL] [Abstract][Full Text] [Related]
19. NLRP3 inflammasome inhibition attenuates subacute neurotoxicity induced by acrylamide in vitro and in vivo.
Sui X; Yang J; Zhang G; Yuan X; Li W; Long J; Luo Y; Li Y; Wang Y
Toxicology; 2020 Feb; 432():152392. PubMed ID: 32014472
[TBL] [Abstract][Full Text] [Related]
20. MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition.
Coll RC; Hill JR; Day CJ; Zamoshnikova A; Boucher D; Massey NL; Chitty JL; Fraser JA; Jennings MP; Robertson AAB; Schroder K
Nat Chem Biol; 2019 Jun; 15(6):556-559. PubMed ID: 31086327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
